|
| Exchange Disseminated Time | Aarti Drugs Ltd has informed BSE that the following:
"Two of the Aarti Drugs Ltd facilities in Tarapur have received an import alert dated March 23, 2015 as per the FDA website. However, only one of that is US FDA facility. Second one, we had already delisted from the US FDA website couple of years back.
For the said E-22 facility, we had a re-inspection in August 2014. Post that, we submitted four responses starting Aug’14 and the last response in Feb’15. We still have to receive an official communication from US FDA on the import alert after which we can take immediate actions to rectify the same.
For the current financial year 2014-15, the total US sales contributes to slightly less than 1% of the total sales volume. Hence this shouldn’t affect our top-line and bottom-line significantly." |
|
|